Your MDD Certificate Has an Expiration Date. Here's What Happens When You Miss It.
MDR transition is not a launch-day issue — it is a certificate-lifecycle issue. This guide explains, in plain terms, the staggered MDR deadlines, Article 120 bridge conditions, Notified Body waitlist reality, and ISO 13485 requirements that determine whether your medical device keeps selling in Europe.
For founders, manufacturers, RA/QA teams, and regulatory consultants. For RA/QA or consultant review.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine MDR classification, conformity assessment route, Notified Body readiness, compliance, safety, or effectiveness. We organize public regulatory sources so qualified RA/QA professionals or regulatory consultants can review and decide.
The Fear You're Actually Feeling
You're afraid of losing your European market access. Not in an abstract “compliance is important” sense. You're afraid of a specific phone call — the one where your distributor says, “We can't order your next shipment until the certificate is resolved.” You're afraid of watching your European revenue line go to zero, not because your device failed, but because your paperwork expired.
You're afraid that you've already waited too long. That the window closed while you were busy building the company. That you're about to become a cautionary tale: the founder who built a great device, got it into Europe, and then lost it all because they didn't understand a regulatory deadline.
Here's the relief: You are not too late. The bridge is still standing. But you need to know exactly where the supports are — and which ones require your weight right now.
The Wrong Frame: “I'll Deal With MDR When I'm Ready to Launch in Europe”
This feels like responsible prioritization. Focus on the U.S. first. Figure out Europe later. But MDR is not a launch-day issue — it is a certificate-lifecycle issue. Your MDD certificate was issued with an expiration date. When that date passes — unless you have met all Article 120 transitional conditions — you cannot legally place your device on the European market.
The frame of “I'll deal with it when I'm ready” assumes the transition window is infinite. It is not. The clock has been running since May 26, 2017 — the day MDR entered into force. If you're reading this and you haven't started, you are not early. You are not on time. But acknowledging that reality today is infinitely better than acknowledging it six months from now. Every week you wait compounds the problem. Every week you act shrinks it.
The Staggered Reality: What Happens If You Do Nothing
The MDR transition is not one deadline. It is a staircase. Each class steps off at a different date. Before any of these deadlines apply, there is a critical gate from May 26, 2024 that you must verify — see the next section.
| Device Class | MDR Transition Deadline | Status |
|---|---|---|
| Class III + Class IIb implantable | December 31, 2027 | Active window |
| Class IIb non-implantable + Class IIa | December 31, 2028 | Active window |
| Class I (sterile/measuring) | December 31, 2028 | Active window |
| Class I (non-sterile, non-measuring) | Already required | Missed if not done — verify urgently |
| Custom-made devices (Class III implantable) | May 26, 2026 | Active window |
Immediate relief: If your device is Class IIa or above, you're still in the window. Urgent warning: Class I non-sterile, non-measuring devices generally needed to meet MDR requirements by May 26, 2021. If your device falls into this category and you have not verified your MDR transition status, consult a qualified regulatory professional urgently.
The Gate You May Have Already Passed (Or Missed): May 26, 2024
Before any of the staggered deadlines above even apply, there is a hard gate. By May 26, 2024, manufacturers seeking to use the extended transition must have (Article 120(3c)):
- An MDR-compliant quality management system in place
- A formal application lodged with a designated Notified Body
If your company did not meet both conditions by this date, the extended transition deadlines may not apply to your devices — regardless of when your MDD certificate expires.
Relief (if you met the gate): If your company lodged an application and has an MDR-compliant QMS by May 26, 2024, you may have met two critical gate conditions — but the full Article 120 bridge requires additional conditions. Relief (if you're uncertain): Confirm this with your regulatory team or qualified consultant immediately. Uncertainty is fixable. A missed gate with no corrective action is not.
The Real Cost: The Notified Body Waitlist That Devours Your Timeline
The number of designated MDR Notified Bodies dropped significantly after MDR was introduced, and the ones that remain are operating at capacity. Notified Bodies are operating at high capacity, and waitlists for new MDR applications are measured in many months — not weeks.
If your Class IIb device has a transition deadline of December 31, 2028, and you start your Notified Body application in January 2028, you are already too late. The Notified Body may not be able to process your application, conduct your audit, and issue your certificate in the time remaining.
What this means for your planning:
- Begin Notified Body engagement as early as possible. Not next quarter. Not after the next funding round. Now.
- Contact your selected Notified Body directly for their current timelines — do not rely on general estimates.
- The waitlist clock runs before your deadline, not after it.
A market gap is not abstract. It means your distributor stops ordering. It means your competitor's MDR-certified device takes your shelf space. It means your European revenue goes to zero — not because your device failed, but because your paperwork expired.
Article 120: The Bridge That Is Still Standing
The transitional provisions in Article 120 of the MDR are what make the staggered deadlines possible. They allow devices with valid MDD certificates to continue being placed on the market under certain conditions — but those conditions are tightening.
Prerequisite — The May 26, 2021 Historical Gate
1. Your MDD certificate must have been valid on May 26, 2021 (Article 120(3)). Certificates that expired before this date are not covered by Article 120.
The May 26, 2024 Gate Conditions
- MDR-compliant quality management system in place (Article 120(3c))
- Formal application lodged with a designated Notified Body (Article 120(3c))
Conditions to Meet by Your Transition Deadline
- Signed written agreement with your Notified Body (Article 120(3d))
- No significant changes in design or intended purpose (Article 120(3e))
- Comply with MDR post-market surveillance, vigilance, and registration requirements (Article 120(3f))
The biggest relief: Under the amended Article 120 (Regulation 2023/607, replacement paragraph 4), the previous “sell-off” deadline was eliminated. Devices lawfully placed on the market under a valid MDD certificate before its expiration may continue to be made available after the certificate expires. Your distributed inventory is safe. But: This does not remove the requirement to obtain MDR certification by your applicable deadline for new units placed on the market. Article 120 is a conditional bridge, not a free extension.
The Counteraction: ISO 13485 Is Your Market Access Insurance
Under MDR, ISO 13485:2016 certification is an explicit requirement. Your QMS must cover:
- Risk management integrated into design and production (EN ISO 14971)
- Clinical evaluation that is continuously updated (not a one-time report)
- Post-market surveillance (PMS) as an active system, not a document
- Unique Device Identification (UDI) assignment and submission to EUDAMED
- Person Responsible for Regulatory Compliance (PRRC) — a named individual
- Supply chain traceability from raw material to end user
| Phase | Duration |
|---|---|
| Gap analysis | 2–4 weeks |
| QMS build or remediation | 3–12 months (depends on current state) |
| Internal audit | 2–4 weeks |
| Certification body audit (Stage 1 + Stage 2) | 3–6 months |
| Certificate issuance | 4–8 weeks after successful audit |
Minimum realistic timeline if starting from scratch: 12–18 months.
This is why the wrong frame — “I'll deal with it when I'm ready” — is so dangerous. You cannot get MDR certification without ISO 13485. You cannot get ISO 13485 overnight. Both timelines run in parallel with your Notified Body engagement, not after it.
The Identity Upgrade: From Reactive Founder to Secure Market Operator
The founders who navigate this transition successfully share one trait: they stop waiting for the anxiety to go away and start converting it into a dated action plan.
| Reactive Founder | Secure Market Operator |
|---|---|
| Dreads the distributor's next email about MDR | Has a transition timeline the distributor can reference |
| Thinks “my device is simple, this won't apply” | Knows Class I is already under MDR |
| Budgets for certification “when we have time” | Has a signed Notified Body agreement in place |
| Treats QMS as documentation to update later | Treats QMS as operational infrastructure to maintain now |
| Assumes there is time | Counts backward from the deadline |
The identity upgrade is simple: you are no longer a founder who has a European market. You are a founder who operates in the European market. Every week of delay is a week your competitor is not delaying.
Your Next Move
The relief you're looking for doesn't come from reading. It comes from acting. Here is the minimum starter path:
- Confirm your device classification under MDR Annex VIII. Classification rules changed. Your device may have moved. This is a one-hour task that determines everything that follows.
- Check your MDD certificate expiration date. If it's already expired, verify whether Article 120 still covers you. If it hasn't expired, mark the date and count backward.
- Contact a designated MDR Notified Body now. Not next quarter. Not after the next funding round. Now. Get on their list. Get a signed agreement.
- Gap your QMS against ISO 13485:2016. If you don't have a certified QMS, start your certification body engagement in parallel with your Notified Body. These timelines run concurrently — not sequentially.
- Build your transition timeline backward from your deadline. If your deadline is December 2028 and your combined QMS + NB timeline is 18 months, your start date was June 2027. If it's already past that date, you're not out of options — but you need to move faster than you planned.
The European medical device market is the second largest in the world. MDR transition is the price of continued access. The price is non-negotiable. The only variable is whether you pay it on your schedule or whether the deadline pays it for you.
Frequently asked questions
What are the EU MDR transition deadlines for medical devices?
Under the amended MDR, the staggered deadlines are: Class III and Class IIb implantable devices — December 31, 2027; Class IIb non-implantable, Class IIa, and Class I sterile/measuring devices — December 31, 2028. Class I non-sterile, non-measuring devices generally needed to meet MDR requirements by May 26, 2021. Custom-made Class III implantable devices have a deadline of May 26, 2026. These extended deadlines only apply if the manufacturer met the Article 120(3c) gate conditions by May 26, 2024. Verify your exact classification and deadline with a qualified regulatory professional.
What are the Article 120 conditions I need to meet to keep selling in Europe?
Article 120 of the amended MDR establishes a conditional bridge. The prerequisite: your MDD certificate must have been valid on May 26, 2021. Gate conditions (must have been met by May 26, 2024): an MDR-compliant quality management system in place and a formal application lodged with a designated Notified Body. Conditions to meet by your transition deadline: a signed written agreement with your Notified Body, no significant changes in design or intended purpose, and compliance with MDR post-market surveillance, vigilance, and registration requirements. Additionally, under the amended Article 120 paragraph 4, devices lawfully placed on the market before MDD certificate expiry may continue to be made available after expiry — the previous sell-off cliff has been removed.
Do I need a Notified Body for MDR, and how long is the waitlist?
Most devices above Class I require a designated MDR Notified Body. The number of MDR-designated Notified Bodies is limited, and they are operating at high capacity. Waitlists for new MDR applications are typically measured in many months — not weeks. You should begin Notified Body engagement as early as possible. Contact your selected Notified Body directly for their current timelines; wait times vary significantly by device code and Notified Body. A signed written agreement with your Notified Body must be in place by your applicable transition deadline under Article 120(3d).
Is ISO 13485 certification required for MDR transition?
Yes. Under MDR, ISO 13485:2016 certification is an explicit requirement. Your quality management system must cover risk management integrated into design and production (EN ISO 14971), continuously updated clinical evaluation, active post-market surveillance (PMS), Unique Device Identification (UDI) assignment and submission to EUDAMED, a named Person Responsible for Regulatory Compliance (PRRC), and supply chain traceability. If starting from scratch, the minimum realistic timeline for ISO 13485 certification is 12–18 months, running in parallel with your Notified Body engagement.
What happens if my MDD certificate expires before I get MDR certification?
If your MDD certificate expires and you have not met all Article 120 transitional conditions, you cannot legally place new units of your device on the European market. This means your distributor stops ordering, your European revenue goes to zero, and competitors with MDR-certified devices can take your shelf space. However, under the amended Article 120 paragraph 4, devices that were lawfully placed on the market before your certificate expired may continue to be made available afterward — your distributed inventory is protected. The key is to start your MDR transition early enough that your MDR certificate is issued before your MDD certificate expires.
Need a transition timeline built for your device?
Browse our full insights library for more regulatory intelligence — classification guides, consultant-prep checklists, safety-history scans, and market-entry research workflows.
Explore all insightsThis is not regulatory, legal, or compliance advice. TrueMedDevice does not determine MDR classification, conformity assessment route, Notified Body readiness, compliance, safety, or effectiveness. We organize public regulatory sources so qualified RA/QA professionals or regulatory consultants can review and decide.
TrueMedDevice provides public-source research and evidence organization support. This page does not determine device classification, MDR conformity assessment route, Notified Body readiness, compliance status, or legal/regulatory obligations. Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals. MDR transition timelines, Article 120 conditions, and device classification must be confirmed by a qualified regulatory professional.
Sources: Regulation (EU) 2017/745 (MDR), as amended by Regulation (EU) 2023/607 and Regulation (EU) 2020/561. Article 120 transitional provisions. EU Commission Medical Devices sector pages. Deadlines cross-checked against EUR-Lex consolidated text. Notified Body capacity varies — contact your selected Notified Body for current timelines.